tiprankstipranks
Radiopharm Theranostics Limited Sponsored ADR (RADX)
NASDAQ:RADX
US Market
RADX
Radiopharm Theranostics Limited Sponsored ADR
RESEARCH TOOLSreports
Want to see RADX full AI Analyst Report?

Radiopharm Theranostics Limited Sponsored ADR (RADX) Revenue

58 Followers
StatisticsMarket CapRevenue

Radiopharm Theranostics Limited Sponsored ADR Revenue

Radiopharm Theranostics Limited Sponsored ADR had a revenue of ― in the quarter ending ―, with ―. This bring the company's revenue in the last twelve months to ―, Decreased ―. In the fiscal year ending Jun 30, 2024, Radiopharm Theranostics Limited Sponsored ADR had annual revenue of 3.63M with 1114.27% growth.
Revenue (ttm)
―
Revenue Growth
110.08%
P/S Ratio
13.90
Revenue/Employee
$259,530
Employees
14
Market Cap
$50.52M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 2024
3.63M3.33M+1,114.27%
Jun 30, 2023
299.23K290.40K+3,288.38%
Jun 30, 2022
8.83K-283.53K-96.98%
Jun 30, 2022
292.36K――